4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
申请人:Novartis AG
公开号:EP2463282A1
公开(公告)日:2012-06-13
The present invention provides a compound of formula (I):
wherein the variants R1, R2, R3, R4, R5, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP (cholesteryl ester transfer protein), and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
Efficient Solution-Phase Parallel Synthesis of 4-SubstitutedN-Protected Piperidines
作者:Xiaoyang Wang、Anna M. Kauppi、Roger Olsson、Fredrik Almqvist
DOI:10.1002/ejoc.200300387
日期:2003.12
Practical conditions for the synthesis of 4-substituted N-protected piperidines through CuCN·2LiBr-catalyzed organozinc additions to 1-acylpyridinium salts and subsequent hydrogen-transfer hydrogen ...